Merck & Co Newsroom

Merck & Co Analyst Ratings

BenzingaJun 18 08:11 ET

HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating

MT NewswiresJun 5 06:25 ET

Merck & Co Analyst Ratings

BenzingaJun 4 13:27 ET

Redburn Atlantic Adjusts Price Target on Merck to $148 From $142

MT NewswiresMay 1 08:23 ET

Merck & Co Analyst Ratings

BenzingaApr 26 11:52 ET

Jefferies Adjusts Merck & Company Price Target to $150 From $145

MT NewswiresApr 26 07:13 ET

Cantor Fitzgerald Adjusts Merck & Co.' Price Target to $155 From $135, Keeps Overweight Rating

MT NewswiresApr 25 12:52 ET

Merck & Co Analyst Ratings

BenzingaApr 18 10:01 ET

Merck & Co Analyst Ratings

BenzingaApr 8 08:13 ET

Merck & Company (MRK) Receives a Buy From Cantor Fitzgerald

TipRanksApr 6 00:22 ET

Merck & Co Analyst Ratings

BenzingaApr 5 09:31 ET

Merck & Co Analyst Ratings

BenzingaApr 1 08:38 ET

Buy Rating on Merck & Co. Affirmed by Daina Graybosch Amidst WINREVAIR's Market Potential and Efficacy

TipRanksMar 29 03:12 ET

Merck & Co Analyst Ratings

BenzingaMar 28 11:44 ET

Truist Securities Raises Merck Price Target to $142 From $139, Maintains Buy Rating

MT NewswiresMar 27 11:17 ET

Merck & Co Analyst Ratings

BenzingaMar 27 08:41 ET

Maintaining Hold on Merck & Co. Amidst Sotatercept's Promising Developments and Revised Sales Projections

TipRanksMar 27 05:50 ET

Merck & Company (MRK) Gets a Buy From Cantor Fitzgerald

TipRanksMar 12 00:20 ET

Societe General Cuts Merck to Sell, Cites Keytruda Patent Expiry

Seeking AlphaMar 11 13:02 ET

Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $135 Price Target

BenzingaMar 11 09:26 ET